- Report
- October 2023
- 206 Pages
Global
From €3059EUR$3,185USD£2,634GBP
€4370EUR$4,550USD£3,762GBP
- Report
- March 2024
- 190 Pages
Global
From €3241EUR$3,374USD£2,790GBP
€3601EUR$3,749USD£3,100GBP
- Report
- August 2023
- 240 Pages
Global
From €1911EUR$1,990USD£1,646GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1921EUR$2,000USD£1,654GBP
- Report
- November 2023
- 630 Pages
Global
From €9124EUR$9,500USD£7,856GBP
- Report
- November 2018
- 161 Pages
Global
From €1321EUR$1,375USD£1,137GBP
€2641EUR$2,750USD£2,274GBP
- Report
- March 2022
- 175 Pages
Global
From €1911EUR$1,990USD£1,646GBP
- Report
- May 2023
- 200 Pages
Global
From €7203EUR$7,500USD£6,202GBP
- Report
- January 2022
- 200 Pages
Global
From €7203EUR$7,500USD£6,202GBP
- Report
- January 2022
- 200 Pages
Global
From €7203EUR$7,500USD£6,202GBP
- Report
- May 2020
- 482 Pages
Global
From €9124EUR$9,500USD£7,856GBP
- Report
- January 2022
- 200 Pages
Global
From €7203EUR$7,500USD£6,202GBP
- Report
- May 2023
- 160 Pages
Global
From €5762EUR$5,999USD£4,961GBP
The Lung Cancer Therapies market is composed of drugs used to treat lung cancer. These drugs are used to target the cancer cells, reduce the size of tumors, and reduce the spread of cancer. Commonly used drugs include chemotherapy, targeted therapy, immunotherapy, and hormone therapy. Chemotherapy is a type of drug therapy that uses drugs to kill cancer cells. Targeted therapy is a type of drug therapy that uses drugs to target specific molecules in cancer cells. Immunotherapy is a type of drug therapy that uses drugs to boost the body’s immune system to fight cancer. Hormone therapy is a type of drug therapy that uses drugs to block the hormones that help cancer cells grow.
Some companies in the Lung Cancer Therapies market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more
